In The News

Original article from: Scientific American posted on April 12, 2017. by Helen Branswell
When the largest Ebola outbreak in history exploded across West Africa in 2014, public health authorities raced to test experimental vaccines and drugs they hoped would quell the massive epidemic.
But the trials process was too slow, and in... More

Original article from: BU Today posted on March 7, 2017. by Art Jahnke
Infectious disease experts and administrators from Boston University told the Boston Biosafety Committee (BBC) on Monday night that the ability to conduct research at Biosafety Level 4 (BSL-4) at BU’s National Emerging Infectious Diseases Laboratory (NEIDL) would speed... More

Original article from: BU Today posted on March 6, 2017. by Sara Rimer
The Boston Public Health Commission will hold a public meeting this evening, Monday, March 6, to discuss a request by Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) for permission to conduct research at Biosafety Level 4 (BSL-4). More

Original article from: BU Today posted on January 23, 2017. by Barbara Moran
In 2014, Ebola exploded across western Africa. It was the worst outbreak of the virus in recorded history, killing more than 11,000 people before it sputtered out in early 2016. In the Republic of Guinea, the epicenter of... More

Original article from: Boston Globe posted on December 29, 2016. by Dante Ramos
For humanity to conquer Ebola and other deadly diseases, we need the right combination of scientists to study them from every possible angle. Where’s that more likely to happen — in a state-of-the-art biolab amid the world’s deepest... More

Original article from: Boston Globe posted on December 24, 2016. by Evan Allen & Felicia Gans
The Centers for Disease Control and Prevention has approved a Biosafety Level 4 laboratory to operate on Boston University’s medical campus in the South End, according to the Boston Public Health Commission.
Scientists in the National... More

Original article from: Live Science posted on October 27, 2016. by Anne Harding
Humans have been battling viruses since before our species had even evolved into its modern form. For some viral diseases, vaccines and antiviral drugs have allowed us to keep infections from spreading widely, and have helped sick people... More

Original article from: BU Research posted on September 30, 2016. by Elizabeth Dougherty
In the book The Hot Zone, author Richard Preston called viruses like Ebola “molecular sharks”—mindless attackers made of almost nothing. Ebola virus, which causes often-fatal hemorrhagic fevers, carries just seven genes, none of which can do much without... More

Original video from: Microbiology Society aired on September 22, 2016
"This week, we went to the ‘Emerging Disease A2Z’ meeting in Boston to speak to some of the delegates about their work.
Science writer David Quammen, author of 'Spillover' and 'Ebola', told us the challenges of writing about emerging diseases."

Original video from: American Society for Microbiology aired on September 24, 2016
Four years after filming 'Threading the NEIDL', Vincent Racaniello and Alan Dove return to the National Emerging Infectious Diseases Laboratory BSL4 facility at Boston University where they speak with science writer David Quammen.
Watch more TWIVs here